LEP and hepatocellular carcinoma: It has been well known that leptin is capable of promoting an aggressive cancer phenotype by stimulating growth, migration and invasion, and enhancement of angiogenesis in both normal and tumor cells including hepatocellular carcinoma and breast cancer [9, 31–34].